Presseinformationen weltweit an Journalisten und Leser verbreiten
Die Tentamus Gruppe beobachtet die COVID-19-Pandemie gründlich und ergreift vorbeugende Maßnahmen, um das Risiko innerhalb unserer globalen Operationen zu verringern. Wir freuen uns bekannt zu geben, dass alle Labore innerhalb der Tentamus Gruppe zu diesem Zeitpunkt weiterhin geöffnet sind. Tentamus Mehr
In October 2020, a complete device qualification of the AscendTM 400 MHz-NMR (Picture 1) used by DSI-pharm was performed to achieve GMP ready status. This was carried out by GMP trained Bruker engineers and included testing the operation of the Mehr
Since the Valsartan scandal in June 2018, there has been a growing interest in the risk assessment of potential traces of toxic nitrosamines in drug substances and products. The Official Medicines Control Laboratories (OMCLs) of the General European OMCL Network Mehr
Adamson Analytical Laboratories is excited to announce that that the capacity for analyses has again been expanded! Stability studies allow you to establish accurate shelf life expectancy for your product, ensuring that it meets quality and safety requirements over it’s Mehr
Ms. Jyothirmai, Director of Megsan Labs, has announced that Megsan now offers special capabilities to support pharmaceutical clients on nitrosamines as per USFDA and EMEA guidelines, using six GCMS and three LCMS devices. Currently, Megsan Labs serve all major Mehr
ISRAC notified Analyst Research Laboratories that it has successfully passed its latest audit and has been rewarded with an extension of its GLP certification. ISRAC is the designated representative of the State of Israel for the recognition of test facilities Mehr
Pixis Labs/ Columbia Food Laboratories merge names to become Columbia Laboratories. Please welcome Columbia Laboratories as the Pacific Northwest’s latest brand for high quality analytical testing. Formerly known collectively as “Pixis Labs” and “Columbia Food Laboratories,” the new name more Mehr
On 26 May, 2020, the Medical Device Directive (MDD) will be replaced by the new Medical Device Regulation (MDR). MDR is designed to be an improved version of MDD, with the major difference being that MDR influences and provides effectiveness Mehr
After almost six years in the former location in Planegg, Semmelweisstr. 3, aromaLAB has moved to its new laboratory and office space in Martinsried. Because of aromaLAB’s steady growth and ambition to continuously improve its analytical services the business segments were Mehr
Nach der Verschmelzung der beiden Tentamus-Unternehmen QSI GmbH mit Sitz in Bremen und der Diapharm Analytics GmbH aus Oldenburg wird die gemeinsame Pharma Division zukünftig DSI-pharm heißen. Dr. Serap Açikgöz, General Manager Pharma der DSI-pharm, berichtet: „DSI-pharm vereint die GMP-zertifizierten Mehr